Your browser doesn't support javascript.
loading
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies.
Temple, William C; Nix, Matthew A; Naik, Akul; Izgutdina, Adila; Huang, Benjamin J; Wicaksono, Gianina; Phojanakong, Paul; Serrano, Juan Antonio Camara; Young, Elizabeth P; Ramos, Emilio; Salangsang, Fernando; Steri, Veronica; Xirenayi, Simayijiang; Hermiston, Michelle; Logan, Aaron C; Stieglitz, Elliot; Wiita, Arun P.
Afiliación
  • Temple WC; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Nix MA; Department of Pediatrics, Division of Allergy, Immunology, and Bone Marrow Transplantation, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Naik A; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Izgutdina A; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Huang BJ; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Wicaksono G; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Phojanakong P; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Serrano JAC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Young EP; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Ramos E; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Salangsang F; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Steri V; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Xirenayi S; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Hermiston M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Logan AC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Stieglitz E; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Wiita AP; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
J Immunother Cancer ; 11(11)2023 11 24.
Article en En | MEDLINE | ID: mdl-38007238
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Camélidos del Nuevo Mundo / Linfoma de Burkitt / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Camélidos del Nuevo Mundo / Linfoma de Burkitt / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido